Glucocorticoids in clinical

[1]  V. Vogel,et al.  Corticosteroid toxicity in neuro-oncology patients , 2007, Journal of Neuro-Oncology.

[2]  L. Benet,et al.  Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: A review , 1980, Journal of Pharmacokinetics and Biopharmaceutics.

[3]  R. Moore,et al.  Disposition of synthetic glucocorticoids I. Pharmacokinetics of dexamethasone in healthy adults , 1979, Journal of Pharmacokinetics and Biopharmaceutics.

[4]  B. Kennedy,et al.  Hypersensitivity Reactions to Etoposide A Case Report and Review of the Literature , 1988, American journal of clinical oncology.

[5]  D. Weissman.  Glucocorticoid treatment for brain metastases and epidural spinal cord compression: a review. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  T. Walsh,et al.  Controlling symptoms in advanced cancer. , 1988, British medical journal.

[7]  M. Greaves,et al.  Potential value of vintristine‐adriamycin‐dexamethasone combination chemotherapy (VAD) in refractory and rapidly progressive myeloma , 1987, European journal of haematology.

[8]  E. Begg,et al.  The pharmacokinetics of corticosteroid agents , 1987, The Medical journal of Australia.

[9]  B. Barlogie,et al.  High-dose glucocorticoid treatment of resistant myeloma. , 1986, Annals of internal medicine.

[10]  C. Gallant,et al.  Oral glucocorticoids and their complications. A review. , 1986, Journal of the American Academy of Dermatology.

[11]  J. Connors,et al.  MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. , 1985, Annals of internal medicine.

[12]  R. Gale,et al.  Recent advances in the biology and treatment of acute lymphoblastic leukemia in adults. , 1984, The New England journal of medicine.

[13]  G. Rosner,et al.  BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study. , 1984, Annals of internal medicine.

[14]  G. Donovitz,et al.  Antiemetic efficacy of high-dose corticosteroids and droperidol in cisplatin-induced emesis: a controlled trial with droperidol and metoclopramide. , 1984, Gynecologic oncology.

[15]  D. Mitchell,et al.  Do corticosteroids really alter mood? , 1984, Postgraduate medical journal.

[16]  M. Lippman.  Steroids in malignant diseases: progress in patient selection. , 1984, Hospital practice.

[17]  B. Barlogie,et al.  Effective treatment of advanced multiple myeloma refractory to alkylating agents. , 1984, The New England journal of medicine.

[18]  C. Bloomfield.  Glucocorticoid receptors in leukemia and lymphoma. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  F. Homo-Delarche.  Glucocorticoid receptors and steroid sensitivity in normal and neoplastic human lymphoid tissues: a review. , 1984, Cancer research.

[20]  C. Bird,et al.  Prednisolone levels in plasma and leukemia cells during therapy of chronic lymphocytic leukemia. , 1984, Journal of pharmaceutical sciences.

[21]  M. Zimmermann,et al.  Guidelines for therapy of pain in cancer patients. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[22]  T. Walsh,et al.  Hospice care: the treatment of pain in advanced cancer. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[23]  J. Vaquero,et al.  Primary cerebral lymphoma: the "ghost tumor". Case report. , 1984, Journal of neurosurgery.

[24]  Denis R. Miller,et al.  Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG‐141: A report from childrens cancer study group , 1983, Cancer.

[25]  R. Fisher,et al.  Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy. , 1983, Annals of internal medicine.

[26]  A. F. Stewart.  Therapy of malignancy-associated hypercalcemia: 1983. , 1983, The American journal of medicine.

[27]  J. Cawley,et al.  Glucocorticoid binding and cytolethal responsiveness of hairy-cell and chronic lymphocytic leukaemia. , 2008, Clinical and laboratory haematology.

[28]  R. Pezner,et al.  Peptic ulcer disease and other complications in patients receiving dexamethasone palliation for brain metastasis. , 1982, The Western journal of medicine.

[29]  J. Armitage,et al.  Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) , 1982, Cancer.

[30]  M. Pasmantier,et al.  Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen. , 1982, Annals of internal medicine.

[31]  R. Baron,et al.  Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. , 1982, The Journal of clinical endocrinology and metabolism.

[32]  J. Posner,et al.  Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients , 1982, Cancer.

[33]  L. Uf,et al.  Marked alterations in prednisolone elimination for women taking oral contraceptives [abstract] , 1982 .

[34]  R. K. Knight,et al.  Corticosteroids for elderly patients with breast cancer , 1981, Cancer.

[35]  H. B. Shumacker.  Management of moderate lymphedema. , 1981, Archives of surgery.

[36]  F. Bochner,et al.  Intraoperative pharmacokinetics of dexamethasone. , 1981, British journal of clinical pharmacology.

[37]  J. Posner,et al.  Epidural spinal cord compression from metastatic tumor: Results with a new treatment protocol , 1980, Annals of neurology.

[38]  G. Mundy,et al.  Effect of calcitonin and glutocorticoids in combination on the hypercalcemia of malignancy. , 1980, Annals of internal medicine.

[39]  V. Devita,et al.  Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. , 1980, Annals of internal medicine.

[40]  M E Pickup,et al.  Clinical Pharmacokinetics of Prednisone and Prednisolone , 1979, Clinical pharmacokinetics.

[41]  T. Lister,et al.  MVPP chemotherapy regimen for advanced Hodgkin's disease , 1978, British medical journal.

[42]  L. Sherwood,et al.  6 – Disorders of Mineral Metabolism in Malignancy , 1978 .

[43]  C. Presant,et al.  Management of superior vena cava syndrome. , 1978, Seminars in oncology.

[44]  A. Meikle,et al.  Effectiveness of prednisolone during phenytoin therapy , 1977, Clinical pharmacology and therapeutics.

[45]  G. Humphrey,et al.  Combination intrathecal therapy for meningeal leukemia: two versus three drugs. , 1977, Blood.

[46]  S. Rosenberg,et al.  Prednisone in MOPP chemotherapy for Hodgkin's disease. , 1976, British medical journal.

[47]  V. Devita,et al.  Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. , 1976, Annals of internal medicine.

[48]  F. H. Tyler,et al.  Kinetics and interconversion of prednisolone and prednisone studied with new radioimmunogassays. , 1975, The Journal of clinical endocrinology and metabolism.

[49]  F. Wilner,et al.  Combination chemotherapy in the treatment of advanced Hodgkin's disease. , 1975, Michigan medicine.

[50]  C. Ditzler,et al.  Bioavailability of dexamethasone; II. Dexamethasone phosphate , 1975, Clinical pharmacology and therapeutics.

[51]  M. D. Shanklin,et al.  Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation. , 1975, British medical journal.

[52]  R. Hahn,et al.  Corticosteroid therapy of preterminal gastrointestinal cancer , 1974, Cancer.

[53]  E. Boldrey,et al.  Dose dependency of decadron in patients with partially excised brain tumors. , 1973, Journal of neurosurgery.

[54]  E. Ezdinli,et al.  Chlorambucil vs. combined chlorambucil‐corticosteroid therapy in chronic lymphocytic leukemia , 1973, Cancer.

[55]  L. Powell,et al.  Corticosteroids in liver disease: Studies on the biological conversion of prednisone to prednisolone and plasma protein binding , 1972, Gut.

[56]  H. Goodpasture,et al.  Clinical correlations during amphotericin B therapy. , 1972, The Journal of the Kansas Medical Society.

[57]  M. Koenig,et al.  Reversible cardiac enlargement during treatment with amphotericin B and hydrocortisone. Report of three cases. , 1971, The American review of respiratory disease.

[58]  A. J. Donovan,et al.  Osseous metastasis in mammary cancer. Response to therapy. , 1970, Archives of surgery.

[59]  J. Wolff,et al.  Varying prednisone dosage in remission induction of previously untreated childhood leukemia , 1968, Cancer.

[60]  J. Wolff,et al.  Prednisone therapy of acute childhood leukemia: prognosis and duration of response in 330 treated patients. , 1967, The Journal of pediatrics.

[61]  H. F. West.  The Adrenal Cortex in Internal Medicine , 1966 .

[62]  G. Mathé,et al.  Extensive Histological and Cytological Survey of Patients with Acute Leukaemia in “Complete Remission”* , 1966, British medical journal.

[63]  T. Vietti,et al.  THE RESPONSE OF ACUTE CHILDHOOD LEUKEMIA TO AN INITIAL AND A SECOND COURSE OF PREDNISONE. , 1965, The Journal of pediatrics.

[64]  J. Galicich,et al.  THE USE OF STEROIDS FOR CONTROL OF CEREBRAL EDEMA. , 1964, Clinical neurosurgery.

[65]  E. Frei,et al.  A Study of Prednisone Therapy in Chronic Lymphocytic Leukemia , 1961 .

[66]  D. Hammond,et al.  Prednisone in childhood leukemia; comparison of interrupted with continuous therapy. , 1959, Pediatrics.

[67]  R. GonzálezBosch.  Treatment of multiple myeloma , 1959 .

[68]  C. Gray,et al.  Adrenal Cortical Hormones in Human Placenta , 1952, Nature.

[69]  F. J. Heck,et al.  Cortisone and ACTH in the management of leukemia and lymphoblastoma. , 1950, Proceedings of the staff meetings. Mayo Clinic.

[70]  C. P. Rhoads,et al.  Acth‐ and cortisone‐induced regression of lymphoid tumors in man. A preliminary report , 1949 .

[71]  E. Kendall,et al.  THE INFLUENCE OF 11-DEHYDR0-17-HYDR0XYCORTICOSTERONE (COMPOUND E) ON THE GROWTH OF A MALIGNANT TUMOR IN THE MOUSE11 , 1944 .

[72]  A. White,et al.  Effect of Pituitary Adrenotropic Hormone on Lymphoid Tissue.∗ , 1943 .